Consistently, zosuquidar reduced PD‐L1 expression under both basal and inducible conditions in NSCLC (NCI‐H1975), ovarian cancer (SKOV3), renal carcinoma (786‐O), and pancreatic cancer (MIA PaCa‐2) (Figure 1C). The gene discussed is CD274; the disease is ovarian carcinoma.